Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1987 1
1988 1
1989 1
1991 1
1994 2
1995 1
1997 3
1998 2
1999 5
2000 2
2001 2
2002 2
2003 6
2004 11
2005 16
2006 15
2007 14
2008 22
2009 21
2010 41
2011 27
2012 48
2013 38
2014 57
2015 62
2016 43
2017 59
2018 42
2019 41
2020 39
2021 63
2022 18
Text availability
Article attribute
Article type
Publication date

Search Results

640 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF, Cheng SY, Bischoff HG, Peled N, Grossi F, Jennens RR, Reck M, Hui R, Garon EB, Boyer M, Rubio-Viqueira B, Novello S, Kurata T, Gray JE, Vida J, Wei Z, Yang J, Raftopoulos H, Pietanza MC, Garassino MC; KEYNOTE-189 Investigators. Gandhi L, et al. Among authors: de angelis f. N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16. N Engl J Med. 2018. PMID: 29658856 Free article. Clinical Trial.
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.
Rodríguez-Abreu D, Powell SF, Hochmair MJ, Gadgeel S, Esteban E, Felip E, Speranza G, De Angelis F, Dómine M, Cheng SY, Bischoff HG, Peled N, Reck M, Hui R, Garon EB, Boyer M, Kurata T, Yang J, Pietanza MC, Souza F, Garassino MC. Rodríguez-Abreu D, et al. Among authors: de angelis f. Ann Oncol. 2021 Jul;32(7):881-895. doi: 10.1016/j.annonc.2021.04.008. Epub 2021 Apr 22. Ann Oncol. 2021. PMID: 33894335 Clinical Trial.
Progression of regional grey matter atrophy in multiple sclerosis.
Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O. Eshaghi A, et al. Among authors: de angelis f. Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088. Brain. 2018. PMID: 29741648 Free PMC article.
Follicular lymphoma.
De Angelis F, Foà R. De Angelis F, et al. Exp Oncol. 2012 Dec;34(4):380-3. Exp Oncol. 2012. PMID: 23303004 Review. No abstract available.
Role of microbes in the pathogenesis of neuropsychiatric disorders.
Goswami A, Wendt FR, Pathak GA, Tylee DS, De Angelis F, De Lillo A, Polimanti R. Goswami A, et al. Among authors: de angelis f. Front Neuroendocrinol. 2021 Jul;62:100917. doi: 10.1016/j.yfrne.2021.100917. Epub 2021 May 4. Front Neuroendocrinol. 2021. PMID: 33957173 Review.
Magneto-Optical Activity in Nonmagnetic Hyperbolic Nanoparticles.
Kuttruff J, Gabbani A, Petrucci G, Zhao Y, Iarossi M, Pedrueza-Villalmanzo E, Dmitriev A, Parracino A, Strangi G, De Angelis F, Brida D, Pineider F, Maccaferri N. Kuttruff J, et al. Among authors: de angelis f. Phys Rev Lett. 2021 Nov 19;127(21):217402. doi: 10.1103/PhysRevLett.127.217402. Phys Rev Lett. 2021. PMID: 34860084
Metals used in maxillofacial surgery.
Pacifici L, DE Angelis F, Orefici A, Cielo A. Pacifici L, et al. Among authors: de angelis f. Oral Implantol (Rome). 2017 Feb 14;9(Suppl 1/2016 to N 4/2016):107-111. doi: 10.11138/orl/2016.9.1S.107. eCollection 2016 Jan-Mar. Oral Implantol (Rome). 2017. PMID: 28280540 Free PMC article. Review.
Defect Activity in Lead Halide Perovskites.
Motti SG, Meggiolaro D, Martani S, Sorrentino R, Barker AJ, De Angelis F, Petrozza A. Motti SG, et al. Among authors: de angelis f. Adv Mater. 2019 Nov;31(47):e1901183. doi: 10.1002/adma.201901183. Epub 2019 Aug 18. Adv Mater. 2019. PMID: 31423684 Review.
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
Connick P, De Angelis F, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D, Prados Carrasco F, Barkhof F, Ourselin S, Braisher M, Ross M, Cranswick G, Pavitt SH, Giovannoni G, Gandini Wheeler-Kingshott CA, Hawkins C, Sharrack B, Bastow R, Weir CJ, Stallard N, Chandran S, Chataway J; UK Multiple Sclerosis Society Clinical Trials Network. Connick P, et al. Among authors: de angelis f. BMJ Open. 2018 Aug 30;8(8):e021944. doi: 10.1136/bmjopen-2018-021944. BMJ Open. 2018. PMID: 30166303 Free PMC article. Clinical Trial.
640 results